Literature DB >> 12114648

Basic Fibroblast Growth Factor Expression by Two Prolactin and Thyrotropin-Producing Pituitary Adenomas.

Shereen Ezzat1, Eva Horvath, Kalman Kovacs, Harley S. Smyth, William Singer, Sylvia L. Asa.   

Abstract

We investigated the expression of basic fibroblast growth factor (bFGF) in an aggressive type of PRL and TSH-producing pituitary adenoma. Immunocytochemistry and electron microscopy were used to characterize the tumors removed from two patients. lmmunoassays were used to measure hormone and bFGF levels in vitro and in vivo. Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect bFGF mRNA expression by these tumors. Morphologically, these tumors were characterized by an unusual plurihormonal pattern with expression of PRL and TSH and the ultrastructural characteristics of the silent subtype 3 adenoma; in addition, both adenomas displayed marked interstitial fibrosis. bFGF was measurable in the circulation of these patients ranging from 7.5-20.5 pg/mL (normal < 1 pg/mL). bFGF concentrations were reduced following surgical adenomectomy. bFCF in culture media was present in concentrations of 197-387 pg/24h/10(5) cells. bFGF mRNA expression was identified in both adenomas examined. bFGF levels were unaltered in the culture media and in the serum of patients following GnRH and TRH treatment. In conclusion, the expression of bFGF by these plurihormonal pituitary adenomas suggests the possibility that it may play a role in the development of fibrosis and tumor cell proliferation of this unusual type of pituitary neoplasm.

Entities:  

Year:  1995        PMID: 12114648     DOI: 10.1007/bf02739875

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  24 in total

1.  The cell-adhesive effect of basic fibroblast growth factor on pituitary cells in vitro.

Authors:  K Inoue; T Sakai; M Hattori
Journal:  J Endocrinol       Date:  1991-09       Impact factor: 4.286

2.  Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.

Authors:  G H Larson; R D Koos; M A Sortino; P M Wise
Journal:  Endocrinology       Date:  1990-02       Impact factor: 4.736

Review 3.  Structural characterization and biological functions of fibroblast growth factor.

Authors:  D Gospodarowicz; N Ferrara; L Schweigerer; G Neufeld
Journal:  Endocr Rev       Date:  1987-05       Impact factor: 19.871

Review 4.  A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development.

Authors:  H A Ingraham; V R Albert; R P Chen; E B Crenshaw 3d; H P Elsholtz; X He; M S Kapiloff; H J Mangalam; L W Swanson; M N Treacy
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

5.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

Authors:  S L Asa; B W Scheithauer; J M Bilbao; E Horvath; N Ryan; K Kovacs; R V Randall; E R Laws; W Singer; J A Linfoot
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

6.  Evolution of the functional human beta-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes.

Authors:  S Y Ng; P Gunning; R Eddy; P Ponte; J Leavitt; T Shows; L Kedes
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

7.  Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors.

Authors:  K A Elias; R I Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Transforming DNA sequences present in human prolactin-secreting pituitary tumors.

Authors:  R Gonsky; V Herman; S Melmed; J Fagin
Journal:  Mol Endocrinol       Date:  1991-11

9.  Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas.

Authors:  S Ezzat; H S Smyth; L Ramyar; S L Asa
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

10.  Human basic fibroblast growth factor: nucleotide sequence and genomic organization.

Authors:  J A Abraham; J L Whang; A Tumolo; A Mergia; J Friedman; D Gospodarowicz; J C Fiddes
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  8 in total

Review 1.  Endocrine/paracrine control of pituitary cell proliferation and its involvement in pituitary tumorigenesis.

Authors:  M Pawlikowski
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

Review 2.  Medical management of thyrotropin-secreting pituitary adenomas.

Authors:  Paolo Beck-Peccoz; Luca Persani
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

3.  Thyroid-stimulating hormone (thyrotropin)-secretion pituitary adenoma in an 8-year-old boy: case report.

Authors:  Yoko Nakayama; Shinya Jinguji; Shin-ichi Kumakura; Keisuke Nagasaki; Manabu Natsumeda; Yuichiro Yoneoka; Takafumi Saito; Yukihiko Fujii
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 4.  Genetic basis of pituitary adenoma invasiveness: a review.

Authors:  A Suhardja; K Kovacs; J Rutka
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

5.  Mediation of basic fibroblast growth factor-induced lactotropic cell proliferation by Src-Ras-mitogen-activated protein kinase p44/42 signaling.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Endocrinology       Date:  2005-01-06       Impact factor: 4.736

6.  Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells.

Authors:  George Vlotides; Yen-Hao Chen; Tamar Eigler; Song-Guang Ren; Shlomo Melmed
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

Review 7.  Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management.

Authors:  Fatemeh G Amlashi; Nicholas A Tritos
Journal:  Endocrine       Date:  2016-01-21       Impact factor: 3.633

8.  Expression of Growth Factors in Normal and Neoplastic Pituitary Tissues.

Authors:  Wolfgang Saeger
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.